No Data
No Data
Traws Pharma Names Nora Brennan CFO
Express News | Traws Pharma Inc - on February 5, Mark Guerin Resigned as CFO of Traws Pharma
Express News | Traws Pharma Inc - No Significant Adverse Events Reported in Phase I Study
Express News | Traws Pharma Announces Completion of Phase I Studies With Tivoxavir Marboxil, a Single Dose Oral Investigational Drug for the Treatment and Prevention of H5N1 Bird Flu
Traws Pharma Files to Sell 7.23M Shares of Common Stock for Holders
Traws Pharma Shares Surge 57% in After-Hours Trading Following Antiviral Trial Update